Wednesday, May 8, 2024
HomeTagsNIH SBIR

NIH SBIR

Infixion Bioscience is Awarded Third NIH SBIR Phase 1 Grant

Infixion Bioscience, a pre-clinical drug discovery company focused on developing gene-targeted therapeutics for the rare genetic disorder Neurofibromatosis Type 1 (NF1), announced the awarding...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics